News and Analysis

Talaris Therapeutics attracts $115m Series B

Talaris Therapeutics Inc, a biotechnology company, has raised $115 million in Series B funding.

-

Talaris Therapeutics Inc, a biotechnology company, has raised $115 million in Series B funding. Surveyor Capital and Viking Global Investors led the round.

Source: Press Release